Launch of Gene Therapies in Europe: How Medical Affairs Teams are Connecting the Dots in Haemophilia
Time: 2:00 pm
day: Day Two
Details:
- Role of medical affairs team in the pre-launch, launch and lifecycle management of gene therapies in blood disorders
- How medical affairs brings value to patients, HCPs, healthcare systems and companies in Europe
- How European medical affairs teams collaborate with internal stakeholders (market access, clinical development, regulatory affairs, marketing, policy, patient engagement & other teams)
- How European medical affairs teams collaborate with external stakeholders (such as patient organisations, HCP organisations, local and international authorities
